We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Ocular toxicity of investigational anti-cancer drugs in early phase clinical trials

    Ocular toxicities arising from anti-cancer drugs occur sporadically and are sometimes underestimated because they are not life-threatening. Reports...

    Shigemasa Takamizawa, Yuki Katsuya, ... Shigenobu Suzuki in Investigational New Drugs
    Article Open access 05 December 2022
  2. Ocular Manifestations of Systemic Diseases

    This book focuses on ocular manifestations of general human diseases with chapters divided according to the human organ system. Specialists in each...

    Alexandr Stepanov, Jan Studnicka
    Book 2024
  3. Adverse events of antibody–drug conjugates on the ocular surface in cancer therapy

    Antibody–drug conjugates consist of a monoclonal antibody attached to a cytotoxic therapeutic molecule by a connector. This association allows a...

    Sandra Domínguez-Llamas, Manuel Caro-Magdaleno, ... Enrique Rodríguez-de-la-Rúa in Clinical and Translational Oncology
    Article Open access 15 July 2023
  4. Ocular metastases profile in a tertiary hospital in São Paulo, Brazil

    Objective

    Ocular metastases are the most common intraocular tumours in adults. Data regarding the occurrence of these tumours in the Brazilian...

    Matheus Senna Pereira Ogata, Guilherme Rodrigues Ferreira, ... Arthur Gustavo Fernandes in International Journal of Retina and Vitreous
    Article Open access 16 April 2024
  5. Ambient ultraviolet radiation and ocular melanoma incidence in the United States, 2000−2019

    Background/Objectives

    Ocular melanoma is a rare, but deadly cancer. This large cancer registry study examines the associations between solar...

    Basilica M. Arockiaraj, Elizabeth K. Cahoon, ... Jim Z. Mai in Eye
    Article Open access 13 February 2024
  6. Novel ocular immunotherapy induces tumor regression in an equine model of ocular surface squamous neoplasia

    Ocular surface squamous neoplasia (OSSN) is the major cause of corneal cancer in man and horses worldwide, and the prevalence of OSSN is increasing...

    Kathryn L. Wotman, Lyndah Chow, ... Steven Dow in Cancer Immunology, Immunotherapy
    Article 11 November 2022
  7. The role of a multicentre data repository in ocular inflammation: The Ocular Autoimmune Systemic Inflammatory Infectious Study (OASIS)

    In the current literature, clinical registry cohorts related to ocular inflammation are few and far between, and there are none involving...

    Sean Ming Sheng Ng, Rebecca Low, ... Alejandra de-la-Torre in Eye
    Article 14 March 2023
  8. Ocular adverse events associated with immune checkpoint inhibitors, a sco** review

    Introduction

    Immune checkpoint inhibitors (ICIs) have become an important part of the treatment of multiple cancers, especially for advanced melanoma...

    A. Martens, P. P. Schauwvlieghe, ... S. Aspeslagh in Journal of Ophthalmic Inflammation and Infection
    Article Open access 22 February 2023
  9. Vision-specific and cancer-specific quality of life in ocular graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

    Purpose

    To compare the vision-specific and cancer-specific quality of life (QOL) between patients with and without ocular graft-versus-host disease...

    Yinglin Liao, Wenxin Zhao, ... Lingyi Liang in Graefe's Archive for Clinical and Experimental Ophthalmology
    Article 27 August 2022
  10. A novel integrated practice unit approach to peri-ocular skin cancer management

    L. Y. Goh, C. Downie, A. M. S. Morley in Eye
    Article 13 February 2024
  11. Are isolated ocular motor nerve palsies in the elderly truly ‘low risk’ for abnormal neuro-imaging outcomes?

    Background

    Neurologically isolated ocular motor nerve palsies often present a management dilemma. Neuroimaging is more likely to be offered to...

    Shu-Yi Claire Chan, Joyce Chia-Lin Hsu, ... Shweta Singhal in Eye
    Article 11 October 2023
  12. Therapeutic potential of Buddleja Polystachya Fresen (stem and leaves) extracts: antimicrobial and cytotoxic properties for ocular disease management

    This study on Buddleja polystachya highlights its phytochemical composition, antimicrobial activity, and cytotoxic impacts. The study emphasizes the...

    Ali Hendi Alghamdi, Asaad Khalid, ... Magbool E. Oraiby in Discover Oncology
    Article Open access 15 July 2024
  13. Unmasking an unusual presentation of Hodgkin’s lymphoma masquerading as ocular inflammation: a case report

    Background

    Hodgkin’s lymphoma (HL) is an extremely rare cause of ocular inflammation that is usually not considered in the typical workup of uveitis...

    Anna Zein-El-Din, Rami Abdo, ... Sayeh Pourjavan in Journal of Medical Case Reports
    Article Open access 04 July 2024
  14. Evaluation of diplopia as a vital and remarkable ocular finding among cancer patients

    Background

    Diplopia is an important and debilitating symptom of malignancies due to different pathogenetic mechanisms. Data is lacking in the...

    Ayşenur Çelik, Sibel Özdoğan in Irish Journal of Medical Science (1971 -)
    Article 02 November 2022
  15. Ocular Myasthenia Gravis

    Purpose of review

    To review the diagnosis and current treatments for ocular myasthenia gravis (OMG) with a focus on recent advances.

    Recent findings ...
    Alexander H. Morrison, Grant T. Liu, Ali G. Hamedani in Current Treatment Options in Neurology
    Article 19 April 2023
  16. Global Perspectives in Ocular Oncology

    Eye cancers vary in presentation depending upon geographic location and access to healthcare. Global Perspectives in Ocular Oncologyoffers an...

    Bhavna V. Chawla, Mary E. Aronow
    Book 2022
  17. Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies

    Background

    Ocular inflammatory diseases, including scleritis and uveitis, have been widely treated with immunomodulatory therapies (IMTs) as a...

    Irmak Karaca, Elaine M. Tran, ... Quan Dong Nguyen in Journal of Ophthalmic Inflammation and Infection
    Article Open access 11 March 2024
  18. Medical treatment for ocular surface squamous neoplasia

    Ocular surface squamous neoplasia (OSSN) is the most common non-melanocytic tumour of the ocular surface. Surgical excision with wide margins using...

    David Monroy, Andres Serrano, ... Carol L. Karp in Eye
    Article 08 February 2023
  19. Systemic and ocular associations in pediatric patients undergoing cataract surgery

    Purpose

    Evaluation for systemic diagnosis is an important part of pediatric cataract management. While there are reports on associated systemic and...

    Bharti R. Nihalani, Deborah K. VanderVeen in Graefe's Archive for Clinical and Experimental Ophthalmology
    Article 15 August 2022
  20. Ocular complications in adults with psoriasis: a cross-sectional study in a referral center in Brazil

    Purpose

    There is limited literature on the ocular manifestations in patients with psoriasis. Therefore, this study aimed to identify the prevalence of...

    Ricardo Danilo Chagas Oliveira, Adriano Cypriano Faneli, ... Luis Claudio Lemos Correia in International Ophthalmology
    Article Open access 05 May 2024
Did you find what you were looking for? Share feedback.